PURPOSE: To modify blood-contacting stainless surfaces by covalently coating them with a serum-protease resistant form of tropoelastin (TE). To demonstrate that the modified TE retains an exposed, cell-adhesive C-terminus that persists in the presence of blood plasma proteases. METHODS: Recombinant human TE and a point mutant variant (R515A) of TE were labeled with (125)Iodine and immobilized on plasma-activated stainless steel (PAC) surfaces. Covalent attachment was confirmed using rigorous detergent washing. As kallikrein and thrombin dominate the serum degradation of tropoelastin, supraphysiological levels of these proteases were incubated with covalently bound TE and R515A, then assayed for protein levels by radioactivity detection. Persistence of the C-terminus was assessed by ELISA. RESULTS: TE was significantly retained covalently on PAC surfaces at 88 ± 5% and 71 ± 5% after treatment with kallikrein and thrombin, respectively. Retention of R515A was 100 ± 1.3% and 87 ± 2.3% after treatment with kallikrein and thrombin, respectively, representing significant improvements over TE. The functionally important C-terminus was cleaved in wild-type TE but retained by R515A. CONCLUSIONS: Protein persists in the presence of human kallikrein and thrombin when covalently immobilized on metal substrata. R515A displays enhanced protease resistance and retains the C-terminus presenting a protein interface that is viable for blood-contacting applications.
PURPOSE: To modify blood-contacting stainless surfaces by covalently coating them with a serum-protease resistant form of tropoelastin (TE). To demonstrate that the modified TE retains an exposed, cell-adhesive C-terminus that persists in the presence of blood plasma proteases. METHODS: Recombinant humanTE and a point mutant variant (R515A) of TE were labeled with (125)Iodine and immobilized on plasma-activated stainless steel (PAC) surfaces. Covalent attachment was confirmed using rigorous detergent washing. As kallikrein and thrombin dominate the serum degradation of tropoelastin, supraphysiological levels of these proteases were incubated with covalently bound TE and R515A, then assayed for protein levels by radioactivity detection. Persistence of the C-terminus was assessed by ELISA. RESULTS:TE was significantly retained covalently on PAC surfaces at 88 ± 5% and 71 ± 5% after treatment with kallikrein and thrombin, respectively. Retention of R515A was 100 ± 1.3% and 87 ± 2.3% after treatment with kallikrein and thrombin, respectively, representing significant improvements over TE. The functionally important C-terminus was cleaved in wild-type TE but retained by R515A. CONCLUSIONS: Protein persists in the presence of human kallikrein and thrombin when covalently immobilized on metal substrata. R515A displays enhanced protease resistance and retains the C-terminus presenting a protein interface that is viable for blood-contacting applications.
Authors: Yongbai Yin; Steven G Wise; Neil J Nosworthy; Anna Waterhouse; Daniel V Bax; Hani Youssef; Michael J Byrom; Marcela M M Bilek; David R McKenzie; Anthony S Weiss; Martin K C Ng Journal: Biomaterials Date: 2009-01-20 Impact factor: 12.479
Authors: Sara Thorslund; Javier Sanchez; Rolf Larsson; Fredrik Nikolajeff; Jonas Bergquist Journal: Colloids Surf B Biointerfaces Date: 2005-10-10 Impact factor: 5.268
Authors: Anfeng Wang; Ting Cao; Haiying Tang; Xuemei Liang; Steven O Salley; K Y Simon Ng Journal: Colloids Surf B Biointerfaces Date: 2005-07-10 Impact factor: 5.268
Authors: Matti A Hiob; Steven G Wise; Alexey Kondyurin; Anna Waterhouse; Marcela M Bilek; Martin K C Ng; Anthony S Weiss Journal: Biomaterials Date: 2013-07-14 Impact factor: 12.479
Authors: Jessica F Almine; Steven G Wise; Matti Hiob; Neeraj Kumar Singh; Krishna Kumar Tiwari; Shireen Vali; Taher Abbasi; Anthony S Weiss Journal: FASEB J Date: 2013-05-13 Impact factor: 5.191